Contact Us: 01282 426380
KM Financial Solutions | U.S. FDA moves to limit ingredients for bulk drug compounding
12971
post-template-default,single,single-post,postid-12971,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

U.S. FDA moves to limit ingredients for bulk drug compounding

22 Mar U.S. FDA moves to limit ingredients for bulk drug compounding

Posted at 18:15h in News by
0 Likes
BOSTON, March 23 (Reuters) – The U.S. Food and Drug
Administration on Friday took steps to restrict what
pharmaceutical ingredients large compounding pharmacies can use
to manufacture drugs in bulk that do not go through the agency’s
approval processes.

No Comments

Sorry, the comment form is closed at this time.